Article
KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010-2013.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Dec 2017
Charlton Mary E, Kahl Amanda R, Greenbaum Alissa A, Karlitz Jordan J, Lin Chi, Lynch Charles F, Chen Vivien W
Abstract excerpt
Purpose:KRAS mutations and tumor location have been associated with response to targeted therapy among patients with stage IV colorectal cancer (CRC) in various trials. This study performed the first population-based examination of associations between KRAS mutations, tumor location, and survival, and assessed factors associated with documented KRAS testing. Methods: Patients with stage IV adenocarcinoma of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
